bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

bioRxiv/medRxiv Discussion Site Activity

Discussion Sites | TRiP Reviews

210 Discussion Links — F1000Prime — All Subjects

Most recent first Page 1: Articles 1-10  | Next

Prediction of multiple conformational states by combining sequence clustering with AlphaFold2
Wayment-Steele, H. K., Ovchinnikov, S., Colwell, L., Kern, D.
10.1101/2022.10.17.512570 — Posted: 2022-10-17 — Discussion: 2022-12-28  F1000Prime
Time-resolved cryo-EM using a combination of droplet microfluidics with on-demand jetting
TORINO, S., Dhurandhar, M., Stroobants, A., Claessens, R., Efremov, R. G.
10.1101/2022.10.21.513149 — Posted: 2022-10-21 — Discussion: 2022-12-21  F1000Prime
Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor
Brown, A. D., Vergunst, K. L., Branch, M., Blair, C. M., Dupre, D. J., Baillie, G. S., Langelaan, D. N.
10.1101/2022.08.28.505448 — Posted: 2022-08-28 — Discussion: 2022-12-19  F1000Prime
Earl Grey: a fully automated user-friendly transposable element annotation and analysis pipeline
Baril, T. J., Imrie, R. M., Hayward, A.
10.1101/2022.06.30.498289 — Posted: 2022-07-02 — Discussion: 2022-11-02  F1000Prime
The Molecular Structure of Anterograde Intraflagellar Transport Trains
Lacey, S. E., Foster, H. E., Pigino, G.
10.1101/2022.08.01.502329 — Posted: 2022-08-01 — Discussion: 2022-11-01  F1000Prime
SARS-CoV-2 S protein antagonizes type I interferon downstream signal pathway through interacting and attenuating phosphorylation of STAT1/STAT2
Ni, W., Li, W., Cai, Z., Guo, W., Zheng, Y., Zhao, Y., Wu, Z., Liang, S., Ye, J., Guo, X., Zhou, D., Wu, X., Zhou, C., Tang, M., Chen, Y., Lan, K., Zhou, L., Xu, K.
10.1101/2022.06.06.494494 — Posted: 2022-06-06 — Discussion: 2022-07-22  F1000Prime
UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits
Thompson, D. J., Wells, D., Selzam, S., Peneva, I., Moore, R., Sharp, K., Tarran, W. A., Beard, E. J., Riveros-Mckay, F., Palmer, D., Seth, P., Harrison, J., Futema, M., Genomics England Research Consortium, , McVean, G., Plagnol, V., Donnelly, P., Weale, M. E.
10.1101/2022.06.16.22276246 — Posted: 2022-06-16 — Discussion: 2022-06-27  F1000Prime
Structural heterogeneity of the microtubule lattice
Guyomar, C., Ku, S., Heumann, J., Bousquet, C., Guilloux, G., Gaillard, N., Heichette, C., Duchesne, L., Steinmetz, M. O., Gibeaux, R., Chretien, D.
10.1101/2021.07.14.452321 — Posted: 2021-07-14 — Discussion: 2022-06-16  F1000Prime
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
Moll, T., Odon, V., Harvey, C., Collins, M., Peden, A., Franklin, J., Graves, E., Marshall, J., dos Santos Souza, C., Zhang, S., Azzouz, M., Gordon, D., Krogan, N., Ferraiuolo, L., Snyder, M., Shaw, P., Rehwinkel, J., Cooper-Knock, J.
10.1101/2022.03.06.483172 — Posted: 2022-03-07 — Discussion: 2022-06-08  F1000Prime
Age-related Immune-Stromal Networks Inhibit Response to Regenerative Immunotherapies
Han, J., Cherry, C., Ruta, A., Maestas, D. R., Mejias, J. C., Nguyen, H. H., Fertig, E. J., Housseau, F., Ganguly, S., Moore, E., Tam, A. J., Pardoll, D. M., Elisseeff, J. H.
10.1101/2021.08.17.456641 — Posted: 2021-08-18 — Discussion: 2022-05-17  F1000Prime

Evaluation Sources